Jiao, X., Yu, W., Qian, J., Chen, Y., Wei, P., Fang, W., & Yu, G. (2018). ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1. BMC Cancer.
Citação norma ChicagoJiao, Xiaodong, Wenlong Yu, Jianxin Qian, Ying Chen, Peilian Wei, Wenzheng Fang, and Guanzhen Yu. "ADAM-17 Is a Poor Prognostic Indicator for Patients With Hilar Cholangiocarcinoma and Is Regulated By FoxM1." BMC Cancer 2018.
MLA CitationJiao, Xiaodong, et al. "ADAM-17 Is a Poor Prognostic Indicator for Patients With Hilar Cholangiocarcinoma and Is Regulated By FoxM1." BMC Cancer 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.